Other
Janda's Approach
Janda's Approach is an intervention with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(33%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(2)
Detailed Status
Completed2
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
completed267%
recruiting133%
Recent Activity
1 active trials
Showing 3 of 3
completednot_applicable
Comparative Effects of Janda and IASTM on UCS
NCT07372391
recruitingnot_applicable
Effects Of Jandas Approach Vs PNF Technique On Pain, ROM, Disability, Endurance And QOL In Patients With LCS
NCT06737900
completednot_applicable
Comparative Effects of Jandas's Approach With and Without Post Isometric Relaxation Technique
NCT06461507
Clinical Trials (3)
Showing 3 of 3 trials
NCT07372391Not Applicable
Comparative Effects of Janda and IASTM on UCS
NCT06737900Not Applicable
Effects Of Jandas Approach Vs PNF Technique On Pain, ROM, Disability, Endurance And QOL In Patients With LCS
NCT06461507Not Applicable
Comparative Effects of Jandas's Approach With and Without Post Isometric Relaxation Technique
All 3 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 3